TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants
Condition: Multiple Sclerosis Intervention: Drug: Natalizumab Sponsors: Biogen; Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials